Bausch Health Companies Inc. Stock
A loss of -1.090% shows a downward development for Bausch Health Companies Inc..
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | -1.090% | -9.688% | 29.412% | 11.257% | -9.673% | -28.245% | -76.190% |
| Opko Health Inc. | 3.480% | 0.885% | 0.000% | 11.328% | 4.568% | -28.679% | -63.415% |
| Repligen Corp. | -0.780% | 10.642% | 11.911% | 47.784% | 0.390% | -9.936% | -33.801% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -5.172% | 0.917% | -38.202% | -55.285% |
Comments
Bausch Health Cos (NYSE:BHC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat